Reaching for the summit in pulmonary arterial hypertension with sotatercept: Results of the ZENITH study
Authors:
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Development of New Intrapulmonary Shunts in Pulmonary Arterial Hypertension Patients Treated with SotaterceptAmerican Journal of Respiratory and Critical Care Medicine, 2025
- Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR)American Journal of Respiratory and Critical Care Medicine, 2025
- Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for DeathNew England Journal of Medicine, 2025
- Effect of sotatercept on circulating proteomics in pulmonary arterial hypertensionEuropean Respiratory Journal, 2024
- Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH)Advances in Therapy, 2023
- Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2023
- Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extensionEuropean Respiratory Journal, 2022
- 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionEuropean Respiratory Journal, 2022
- Sotatercept for the Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2021
- Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectivesEuropean Respiratory Journal, 2019